The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

VRTX FINANCIAL STATEMENTS

Vertex Pharmaceuticals Inc — balance sheet, income statement and cash flow trends

VRTXVertex Pharmaceuticals Inc

🇺🇸 USA · US · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
05 B10 B202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue12.6 B $Gross Profit10.9 B $ · 86%Operating Income4.9 B $ · 39%Pre-tax Income5.3 B $ · 42%Net Income to Owners4.4 B $ · 35%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue12.6 B $+10.6%
Gross Profit10.9 B $+10.5%
Operating Income4.9 B $+24.2%
EBITDA5.4 B $+18.6%
Net Income to Owners4.4 B $+21.1%

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
010 B20 B202120222023202420252026

Capital Structure

Q2 2026
Total Assets27.4 B
  • Equity20.2 B $74%
  • Current Liabilities3.9 B $14%
  • Long-term Liabilities3.2 B $12%

Key Figures

YoY change
Total Assets27.4 B $+14.1%
Total Liabilities7.2 B $+4.6%
Total Equity20.2 B $+17.9%
Cash & ST Investments7.9 B $+23.0%
Total Debt2 B $+29.5%
Net Debt-4.2 B $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
02 B4 B202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
02 B4 B4.3 B $Operating-882.8 M $Investing-2.2 B $Financing1.2 B $Net Change

Key Figures

YoY change
Operating Cash Flow4.3 B $+11.6%
Capital Expenditures496.8 M $+43.3%
Free Cash Flow3.8 B $+8.5%
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on VRTX

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 11, 26. This content is for informational purposes only and is not investment advice.